United Kingdom, Intermediaries

Global health care: the era of innovation

In this three-minute video, veteran Portfolio Manager and Global Industry Analyst Jean Hynes offers a high-level overview of three key areas of innovation and growth potential in the health care markets.

The views expressed are those of the authors at the time of writing. Individual teams may hold different views. The value of your investment may become worth more or less than at the time of original investment.

From immuno-oncology to genetic therapies to new medical technology, the health care sector is incredibly exciting. Jean shares intriguing investment opportunities and describes how Wellington’s Health Care Team works to identify them.

Please see the important disclosure page for more information.

For a deeper dive on advances in medical devices — an often underappreciated area of innovation — please see the following white paper from Health Care Team members Ann Gallo, Fayyaz Mujtaba, and Rebecca Sykes.
The future of health care innovation

RECOMMENDED FOR YOU

The post-COVID recovery in Europe
Europe's economic rebound from the COVID pandemic will be stronger than expected, argues Macro Strategist Jens Larsen. He explains why he thinks improved policy will lead the continent out of recession.
January 2021
The post-COVID recovery in Europe
,
2021 Investment Outlook
As we head into the new year, thought leaders from across our investment platform share their views on pressing questions.
December 2020
2021 Investment Outlook
,
2021 Equity Outlook
In our 2021 Equity Outlook we offer our Fundamental Factor Team's latest insights, share multiple views on value investing, explore the latest opportunities in emerging markets post COVID, profile the increasing impact of innovation and technology, and outline Wellington’s growing ESG integration capabilities.
December 2020
2021 Equity Outlook
,
Harnessing disruption: the enduring case for tech and innovation
In this short video, Bruce Glazer and Brian Barbetta, the portfolio managers of the Wellington Disruptive Technology & Innovation Fund, offer their views on disruption and highlight how they seek to take advantage of disruptive technologies and innovations in clients’ portfolios.
November 2020
Harnessing disruption: the enduring case for tech and innovation
,
The future of alternative investments
Director of Alternatives Danny Sharp explores the future of alts — discussing dispersion in today's markets, the opportunities it presents and the impact of the COVID-19 pandemic on the alternative investments landscape.
November 2020
The future of alternative investments
,
EMs: With great challenges come great opportunities
From health and wellness to climate change and more, the COVID-19 crisis has spawned or accelerated compelling investable themes across a range of EM countries. Against that backdrop, four of Wellington’s EM equity portfolio managers share their latest insights.
October 2020
EMs: With great challenges come great opportunities
,
Tracking the green transition in emerging markets
COVID-19 has ratcheted up environmental debates across emerging markets and highlighted the intersection of those concerns with local supply chains and infrastructure gaps. Equity Portfolio Manager Liliana Castillo Dearth looks at China as a case study.
October 2020
Tracking the green transition in emerging markets
,
The dawn of divergence and the art of subtlety
Multi-Asset Strategist Nick Samouilhan highlights the key divergences we should start to see as fundamental differences between companies, sectors, and countries begin to matter more.
October 2020
The dawn of divergence and the art of subtlety
,
Nick Samouilhan
 PhD, CFA, FRM